IQVIA

IQVIA IQV Stock

$257.81   0.079576%
Add to favorites
Exchange
Market Cap
$42.49B
LOW - HIGH [24H]
$254.32 - $259.52
VOLUME [24H]
$1.10M
P/E Ratio
31.36
Earnings per share
$8.22
ISIN
US46266C1053
Price   Prediction

IQVIA Price Chart

Sorry, that's all we've gotfor now...

IQVIA (IQV) stock price today is 257.81 USD on NYSE (+0.08% on the day). Updated .

IQVIA IQV Financial and Trading Overview

IQVIA stock price 257.81 USD
Previous Close 265.12 USD
Open 266.02 USD
Bid 265.46 USD x 4000
Ask 264.69 USD x 12000
Day's Range 260.75 - 266.02 USD
52 Week Range 154.5 - 284.5 USD
Volume 1.49M USD
Avg. Volume 1.45M USD
Market Cap 43.63B USD
Beta (5Y Monthly) 1.165
PE Ratio (TTM) 32.205597
EPS (TTM) 8.22 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 311.89 USD

IQV Valuation Measures

Enterprise Value 57.65B USD
Trailing P/E 32.205597
Forward P/E 18.637695
PEG Ratio (5 yr expected) 0.98
Price/Sales (ttm) 2.5202186
Price/Book (mrq) 6.5506153
Enterprise Value/Revenue 3.33
Enterprise Value/EBITDA 18.49

Trading Information

IQVIA Stock Price History

Beta (5Y Monthly) 1.165
52-Week Change 22.67%
S&P500 52-Week Change 13.32%
52 Week High 284.5 USD
52 Week Low 154.5 USD
50-Day Moving Average 267.41 USD
200-Day Moving Average 211.03 USD

IQV Share Statistics

Avg. Volume (3 month) 1.45M USD
Avg. Daily Volume (10-Days) 1.41M USD
Shares Outstanding 164.8M
Float 156.45M
Short Ratio 2.21
% Held by Insiders 1.26%
% Held by Institutions 102.79%
Shares Short 3.04M
Short % of Float 2.13%
Short % of Shares Outstanding 1.84%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 8.05%
Operating Margin (ttm) 13.88%
Gross Margin 33.06%
EBITDA Margin 18.01%

Management Effectiveness

Return on Assets (ttm) 5.07%
Return on Equity (ttm) 21.39%

Income Statement

Revenue (ttm) 17.31B USD
Revenue Per Share (ttm) 103.5 USD
Quarterly Revenue Growth (yoy) 8.00%
Gross Profit (ttm) 5.72B USD
EBITDA 3.12B USD
Net Income Avi to Common (ttm) 1.39B USD
Diluted EPS (ttm) 8.22
Quarterly Earnings Growth (yoy) 5.70%

Balance Sheet

Total Cash (mrq) 2.42B USD
Total Cash Per Share (mrq) 14.7 USD
Total Debt (mrq) 16.31B USD
Total Debt/Equity (mrq) 240.23 USD
Current Ratio (mrq) 0.829
Book Value Per Share (mrq) 40.413

Cash Flow Statement

Operating Cash Flow (ttm) 2.74B USD
Levered Free Cash Flow (ttm) 2.12B USD

Profile of IQVIA

Country United States
State NC
City Durham
Address 2400 Ellis Road
ZIP 27703
Phone 919 998 2000
Website https://www.iqvia.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 95000

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Q&A For IQVIA Stock

What is a current IQV stock price?

IQVIA IQV stock price today per share is 257.81 USD.

How to purchase IQVIA stock?

You can buy IQV shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for IQVIA?

The stock symbol or ticker of IQVIA is IQV.

Which industry does the IQVIA company belong to?

The IQVIA industry is Diagnostics & Research.

How many shares does IQVIA have in circulation?

The max supply of IQVIA shares is 164.8M.

What is IQVIA Price to Earnings Ratio (PE Ratio)?

IQVIA PE Ratio is 31.36313600 now.

What was IQVIA earnings per share over the trailing 12 months (TTM)?

IQVIA EPS is 8.22 USD over the trailing 12 months.

Which sector does the IQVIA company belong to?

The IQVIA sector is Healthcare.

IQVIA IQV included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us S&P 500 (Yahoo.com) GSPC US 7323.63 USD —
-0.23
3.03B USD — 7285.76 USD — 7367.68 USD — — 3.03B USD —
us S&P 500 INDEX SPX US 7323.63 USD —
-0.23
3.02B USD — 7285.76 USD — 7367.68 USD — — 3.02B USD —
us US Tech US Price Setters Index NQPRCE US 3157.48 USD —
-0.37
— — 3146.41 USD — 3170.94 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us NYSE Composite Index NYA US 23559.61 USD —
-1.06
— — 23530.84 USD — 23742.73 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3640.82 USD —
+0.48
— — 3611.7 USD — 3667.39 USD — — — —
$2.17T
Total marketcap
$71.11B
Total volume
BTC 57.99%   •   ETH 9.91%
Dominance
Select currency